ATE198704T1 - Verfahren zur herstellung eines virus aerosols - Google Patents

Verfahren zur herstellung eines virus aerosols

Info

Publication number
ATE198704T1
ATE198704T1 AT94931633T AT94931633T ATE198704T1 AT E198704 T1 ATE198704 T1 AT E198704T1 AT 94931633 T AT94931633 T AT 94931633T AT 94931633 T AT94931633 T AT 94931633T AT E198704 T1 ATE198704 T1 AT E198704T1
Authority
AT
Austria
Prior art keywords
producing
aerosol
virus
virus aerosol
viral
Prior art date
Application number
AT94931633T
Other languages
English (en)
Inventor
Claude Sene
Didier Lamy
Original Assignee
Transgene Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Transgene Sa filed Critical Transgene Sa
Application granted granted Critical
Publication of ATE198704T1 publication Critical patent/ATE198704T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0078—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a nebulizer such as a jet nebulizer, ultrasonic nebulizer, e.g. in the form of aqueous drug solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pulmonology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Dispersion Chemistry (AREA)
  • Otolaryngology (AREA)
  • Immunology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Colloid Chemistry (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
AT94931633T 1993-10-26 1994-10-26 Verfahren zur herstellung eines virus aerosols ATE198704T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9312743A FR2711523B1 (fr) 1993-10-26 1993-10-26 Procédé de préparation d'un aérosol viral.
PCT/FR1994/001245 WO1995011664A1 (fr) 1993-10-26 1994-10-26 Procede de preparation d'un aerosol viral

Publications (1)

Publication Number Publication Date
ATE198704T1 true ATE198704T1 (de) 2001-02-15

Family

ID=9452211

Family Applications (1)

Application Number Title Priority Date Filing Date
AT94931633T ATE198704T1 (de) 1993-10-26 1994-10-26 Verfahren zur herstellung eines virus aerosols

Country Status (13)

Country Link
US (3) US5952220A (de)
EP (1) EP0680315B1 (de)
JP (1) JP4110329B2 (de)
AT (1) ATE198704T1 (de)
AU (1) AU683954B2 (de)
CA (1) CA2152505C (de)
DE (1) DE69426596T2 (de)
DK (1) DK0680315T3 (de)
ES (1) ES2152993T3 (de)
FR (1) FR2711523B1 (de)
GR (1) GR3035541T3 (de)
PT (1) PT680315E (de)
WO (1) WO1995011664A1 (de)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2751343B1 (fr) * 1996-07-16 1998-12-18 Transgene Sa Procede de conservation de virus recombinants infectieux, suspension aqueuse virale et utilisation comme medicament
DK1180159T3 (da) * 1999-05-28 2008-11-17 Targeted Genetics Corp Fremgangsmåder og sammensætninger til at sænke niveauet af Tumor-Nekrose-Faktor (TNF) i TNF-associerede lidelser
CA2391348A1 (en) * 1999-07-29 2001-02-08 Assem Ziady Enhanced delivery via serpin enzyme complex receptor
ATE538205T1 (de) * 1999-11-29 2012-01-15 Midwest Oilseeds Inc Verfahren, medien und vorrichtung zur einführung von molekülen in pflanzenzellen und bakterien mittels aerosolstrahlen
US20020198139A1 (en) * 2001-05-17 2002-12-26 Deutschman Clifford S. Method of preventing acute pulmonary cell injury
US20030157030A1 (en) 2001-11-02 2003-08-21 Insert Therapeutics, Inc. Methods and compositions for therapeutic use of rna interference
US6845929B2 (en) * 2002-03-22 2005-01-25 Ali Dolatabadi High efficiency nozzle for thermal spray of high quality, low oxide content coatings
ATE500267T1 (de) 2003-07-21 2011-03-15 Transgene Sa Multifunktionelle cytokine
JP2008537551A (ja) 2005-03-31 2008-09-18 カランド ファーマシューティカルズ， インコーポレイテッド リボヌクレオチドレダクターゼサブユニット２の阻害剤およびその使用
WO2007053696A2 (en) 2005-11-01 2007-05-10 Alnylam Pharmaceuticals, Inc. Rnai inhibition of influenza virus replication
US8229398B2 (en) * 2006-01-30 2012-07-24 Qualcomm Incorporated GSM authentication in a CDMA network
EP1993611A4 (de) * 2006-03-16 2013-05-22 Alnylam Pharmaceuticals Inc Rnai-modulation von tgf-beta und ihre therapeutische verwendung
CN101489566B (zh) 2006-05-19 2012-04-18 阿尔尼拉姆医药品有限公司 Aha基因的RNAi调控及其治疗性应用
DE102007020578A1 (de) * 2007-05-02 2008-11-06 Boehringer Ingelheim Pharma Gmbh & Co. Kg Wässrige Aerosolzubereitungen enthaltend therapeutisch wirksame Mikroorganismen oder Teile von Mikroorganismen und Verfahren zur Erzeugung entsprechender Aerosole
AU2009232355A1 (en) 2008-04-04 2009-10-08 Calando Pharmaceuticals, Inc. Compositions and use of EPAS1 inhibitors
US9561514B2 (en) * 2010-12-07 2017-02-07 University Of Florida Research Foundation, Inc. Spraying system and methods of use thereof
EP3587455A1 (de) 2012-10-23 2020-01-01 Emory University Gm-csf- und il-4-konjugate, zusammensetzungen und zugehörige verfahren
US10253071B2 (en) 2013-06-03 2019-04-09 Beth Israel Deaconess Medical Center, Inc. Selectin inhibitors, composition, and uses related thereto
CA2959104A1 (en) 2014-08-26 2016-03-03 Hsf Pharmaceuticals Novel immunization agents and methods of use
US20210401968A1 (en) 2018-03-08 2021-12-30 Hsf Pharmaceuticals Sa Localized activation of virus replicatio boosts herpesvirus-vectored vaccines
WO2020061528A1 (en) 2018-09-21 2020-03-26 University Of Connecticut Compositions and methods to restore paternal ube3a gene expression in human angelman syndrome
EP3653716A1 (de) 2018-11-19 2020-05-20 HSF Pharmaceuticals Replikationskompetente gesteuerte alpha-herpesvirus-virusvektoren und verwendungen davon
EP3921334A1 (de) * 2019-02-08 2021-12-15 Krystal Biotech, Inc. Zusammensetzungen und verfahren zur verabreichung von cftr-polypeptiden
US20240229065A1 (en) 2020-04-24 2024-07-11 Hsf Pharmaceuticals Sa Replication-competent controlled herpesviruses expressing a sars cov-2 antigen
WO2022173689A1 (en) 2021-02-09 2022-08-18 University Of Georgia Research Foundation, Inc. Human monoclonal antibodies against pneumococcal antigens
EP4507720A1 (de) 2022-04-14 2025-02-19 Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. Alpha-1-antitrypsin zur behandlung von paramyxoviridae- oder orthomyxoviridae-infektionen
WO2025214935A1 (en) 2024-04-11 2025-10-16 Hsf Pharmaceuticals Sa Recombinant alphaherpesvirus vectors

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4039656A (en) * 1971-12-10 1977-08-02 Bayer Aktiengesellschaft Production of attenuated viruses
FR2423217A2 (fr) * 1978-03-10 1979-11-16 Anvar Procede de vaccination contre la myxomatose
US4554158A (en) * 1983-04-07 1985-11-19 Simonsen Laboratories, Inc. Modified live sendai virus vaccine for administering through an aerosol and method of producing the same
US4649911A (en) * 1983-09-08 1987-03-17 Baylor College Of Medicine Small particle aerosol generator for treatment of respiratory disease including the lungs
JP2656944B2 (ja) * 1987-04-30 1997-09-24 クーパー ラボラトリーズ タンパク質性治療剤のエアロゾール化
US5240846A (en) 1989-08-22 1993-08-31 The Regents Of The University Of Michigan Gene therapy vector for cystic fibrosis
US6013638A (en) * 1991-10-02 2000-01-11 The United States Of America As Represented By The Department Of Health And Human Services Adenovirus comprising deletions on the E1A, E1B and E3 regions for transfer of genes to the lung
US6001644A (en) * 1991-12-17 1999-12-14 The Regents Of The University Of California Mammalian transformation complex comprising a lipid carrier and DNA encoding CFTR
US5858784A (en) * 1991-12-17 1999-01-12 The Regents Of The University Of California Expression of cloned genes in the lung by aerosol- and liposome-based delivery
US7769623B2 (en) * 2002-12-17 2010-08-03 International Business Machines Corporation Method and system for conducting online marketing research in a controlled manner

Also Published As

Publication number Publication date
WO1995011664A1 (fr) 1995-05-04
US6344194B1 (en) 2002-02-05
US6582694B2 (en) 2003-06-24
US20020106349A1 (en) 2002-08-08
DE69426596D1 (de) 2001-02-22
GR3035541T3 (en) 2001-06-29
DK0680315T3 (da) 2001-02-26
DE69426596T2 (de) 2001-05-31
ES2152993T3 (es) 2001-02-16
FR2711523B1 (fr) 1996-02-16
EP0680315B1 (de) 2001-01-17
CA2152505C (fr) 2005-04-26
JP4110329B2 (ja) 2008-07-02
JPH08505405A (ja) 1996-06-11
EP0680315A1 (de) 1995-11-08
FR2711523A1 (fr) 1995-05-05
AU8063994A (en) 1995-05-22
PT680315E (pt) 2001-05-31
CA2152505A1 (fr) 1995-05-04
US5952220A (en) 1999-09-14
AU683954B2 (en) 1997-11-27

Similar Documents

Publication Publication Date Title
ATE198704T1 (de) Verfahren zur herstellung eines virus aerosols
GB9420355D0 (en) Preparation of protein microspheres, films and coatings
ATE116156T1 (de) Verfahren zur herstellung von aluminiumoxidkugeln.
DE3762615D1 (de) Verfahren zur herstellung von (2,2)-paracyclophan und dessen derivaten.
DE69033600D1 (de) Verfahren zur Isolierung von Haemopnilus influenzae Protein-E
ES2013531A6 (es) Procedimiento de obtencion de vehiculos para encapsular moleculas viajeras.
DE59009658D1 (de) Verfahren zur herstellung von wässrigen dispersionen.
ATE126223T1 (de) Verfahren zur herstellung von ascorbinsäure.
DE3762236D1 (de) Verfahren zur herstellung von (2,2)-paracyclophan und dessen derivaten.
ATE265884T1 (de) Verfahren zur herstellung von imidazolin abgeleiteten amphoacetat-tensiden von höherer reinheit
DE60034601D1 (de) Verfahren zur herstellung von polyphenolischen adhäsionsproteinen
DE69403210D1 (de) Verfahren zur herstellung von n-acetylneuraminsäure
AU631321B2 (en) Process for the preparation of substituted and unsubstituted-2,3-pyridinedicarboxylates from chloromaleate or chlorofumurate or mixtures thereof
ATE334219T1 (de) Verfahren zur reinigung von 1,3-propandiol aus einem fermentationsmedium
ATE146097T1 (de) Verfahren zur herstellung einer wässrigen lösung von natriumhydroxid
RU94020722A (ru) Способ получения наносимой распылением прозрачной водной композиции, имеющей пониженное содержание микропены
GB9220327D0 (en) Process
ATE107925T1 (de) Verfahren zur herstellung perfluorierter heterocyclischer verbindungen und nach diesem verfahren hergestellte verbindungen.
DE59408450D1 (de) Wässriges Liposomensystem sowie Verfahren zur Herstellung eines derartigen Liposomensystems
IE45285L (en) Polyribonucleotides.
ATE284837T1 (de) Verfahren zur herstellung einer salzfreien, waessrigen hydroxylaminloesung
ATE101041T1 (de) Verfahren zur herstellung eines stabilen faktors viii.
ATA186795A (de) Verfahren zur fällung von alkalisalzen der clavulansäure
MX9701880A (es) Proceso para producir acidos aminocarboxilicos que tienen bajo contenido de sal residual.
ATE62235T1 (de) Verfahren zur herstellung von 6-amino-3-hydrazino-pyridazinderivaten.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee